Akoya Biosciences Inc. (AKYA) NASDAQ
$3.81 - (-)
Market Cap: $188.14M
As of 04/24/24 04:00 PM EDT. Market closed.
Akoya Biosciences Inc. (AKYA)
NASDAQ
$3.81
- (-)
Market Cap: $188.14M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
akoya biosciences is developing a novel high-parameter tissue analysis platform, at an order of magnitude beyond what is currently possible. our codex (tm) (co-detection by indexing) system enables deep proteomic profiling.?..all on your existing microscope?. if you are a scientist or software engineer interested in revolutionizing the science of imaging, then akoya is the place for you. contact ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
348
URL
Address
.
PRICE CHART FOR AKOYA BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$3.81
Days Range
$3.73 - $3.86
52 week range
$3.04 - $8.80
Volume
103,157
Avg. Volume (30 days)
153,017
Market Cap
$188.14M
Dividend Yield
-
P/E
(2.97)
Shares Outstanding
49,380,232
Open
-
Previous Close
$3.81
Days Range
$3.73 - $3.86
52 week range
$3.04 - $8.80
Volume
103,157
Avg. Volume (30 days)
153,017
Market Cap
$188.14M
Dividend Yield
-
P/E
(2.97)
Shares Outstanding
49,380,232
FINANCIAL STATEMENTS FOR AKOYA BIOSCIENCES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AKOYA BIOSCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Ek John Frederick | CFO | Apr 01, 2024 | Option Exercise | $4.56 | 14,272 | 65,080 | 180,728 | Apr 02, 2024, 04:41 PM |
| Pla Frederic | Chief Operating Officer | Mar 23, 2024 | Option Exercise | $4.79 | 2,006 | 9,609 | 101,500 | Mar 25, 2024, 05:16 PM |
| Ramachandran Niro Ph.D | Chief Business Officer | Mar 23, 2024 | Option Exercise | $4.79 | 2,006 | 9,609 | 207,924 | Mar 25, 2024, 05:14 PM |
| McKelligon Brian | President and CEO | Mar 23, 2024 | Option Exercise | $4.79 | 7,135 | 34,177 | 224,733 | Mar 25, 2024, 05:12 PM |
| McKelligon Brian | President and CEO | Mar 20, 2024 | Option Exercise | $0.30 | 7,500 | 2,273 | 239,368 | Mar 22, 2024, 05:54 PM |
| McKelligon Brian | President and CEO | Mar 20, 2024 | Sale | $4.97 | 7,500 | 37,243 | 231,868 | Mar 22, 2024, 05:54 PM |
| McKelligon Brian | President and CEO | Mar 13, 2024 | Option Exercise | $0.30 | 7,500 | 2,273 | 239,368 | Mar 22, 2024, 05:51 PM |
| McKelligon Brian | President and CEO | Mar 13, 2024 | Sale | $4.94 | 7,500 | 37,043 | 231,868 | Mar 22, 2024, 05:51 PM |
| McKelligon Brian | President and CEO | Mar 13, 2024 | Sale | $4.94 | 7,500 | 37,035 | 224,368 | Mar 14, 2024, 08:41 PM |
| McKelligon Brian | President and CEO | Mar 01, 2024 | Option Exercise | $6.03 | 8,195 | 49,416 | 231,868 | Mar 04, 2024, 06:01 AM |
| Kamocsay Jennifer | General Counsel | Mar 01, 2024 | Option Exercise | $6.03 | 3,283 | 19,796 | 99,217 | Mar 01, 2024, 09:53 PM |
| Pla Frederic | Chief Operating Officer | Mar 01, 2024 | Option Exercise | $6.03 | 2,049 | 12,355 | 103,506 | Mar 01, 2024, 09:52 PM |
| Ramachandran Niro Ph.D | Chief Business Officer | Mar 01, 2024 | Option Exercise | $6.03 | 2,305 | 13,899 | 209,930 | Mar 01, 2024, 09:52 PM |
| McKelligon Brian | President and CEO | Mar 01, 2024 | Option Exercise | $6.03 | 10,244 | 61,771 | 231,868 | Mar 01, 2024, 09:21 PM |
| McKelligon Brian | President and CEO | Dec 19, 2023 | Option Exercise | $0.30 | 7,500 | 2,273 | 160,063 | Dec 20, 2023, 07:16 PM |
| McKelligon Brian | President and CEO | Dec 19, 2023 | Sale | $4.48 | 7,500 | 33,565 | 152,563 | Dec 20, 2023, 07:16 PM |
| McKelligon Brian | President and CEO | Dec 12, 2023 | Option Exercise | $0.30 | 7,500 | 2,273 | 160,063 | Dec 14, 2023, 04:24 PM |
| McKelligon Brian | President and CEO | Dec 12, 2023 | Sale | $4.25 | 7,500 | 31,871 | 152,563 | Dec 14, 2023, 04:24 PM |
| Pla Frederic | Chief Operating Officer | Sep 07, 2023 | Buy | $4.60 | 20,000 | 92,014 | 20,000 | Sep 11, 2023, 04:00 PM |
| Ek John Frederick | CFO | Jun 12, 2023 | Buy | $5.00 | 20,000 | 100,000 | 20,000 | Jun 12, 2023, 06:18 PM |
| LAI GOLDMAN MYLA | Director | Jun 12, 2023 | Buy | $5.00 | 20,000 | 100,000 | 20,000 | Jun 12, 2023, 06:18 PM |
| Mendel Scott | Director | Jun 12, 2023 | Buy | $5.00 | 20,000 | 100,000 | 28,500 | Jun 12, 2023, 06:17 PM |
| Winkler Matthew | Director | Jun 12, 2023 | Buy | $5.00 | 203,388 | 1,016,940 | 984,513 | Jun 12, 2023, 06:16 PM |
| SHEPLER ROBERT G | Director | Jun 12, 2023 | Buy | $5.00 | 120,000 | 600,000 | 369,592 | Jun 12, 2023, 06:16 PM |
| Raffin Thomas A. | Director | Jun 12, 2023 | Buy | $5.00 | 2,000,000 | 10,000,000 | 15,937,535 | Jun 12, 2023, 06:15 PM |
| Raffin Thomas A. | Director | Jun 12, 2023 | Buy | $5.00 | 20,000 | 100,000 | 234,592 | Jun 12, 2023, 06:15 PM |
| McKelligon Brian | President/CEO | Jun 06, 2023 | Option Exercise | $0.30 | 5,000 | 1,515 | 157,563 | Jun 06, 2023, 09:45 PM |
| McKelligon Brian | President/CEO | Jun 06, 2023 | Sale | $5.71 | 5,000 | 28,537 | 152,563 | Jun 06, 2023, 09:45 PM |
| Nolan Garry Ph.D. | Director | Dec 13, 2022 | Sale | $13.25 | 100 | 1,325 | 555,084 | Mar 27, 2023, 08:12 PM |
| Ramachandran Niro Ph.D | Chief Business Officer | Mar 23, 2023 | Option Exercise | $7.69 | 1,945 | 14,957 | 177,235 | Mar 27, 2023, 08:09 PM |
| Pla Frederic | Chief Operating Officer | Mar 23, 2023 | Option Exercise | $7.69 | 1,945 | 14,957 | 40,555 | Mar 27, 2023, 08:07 PM |
| McKelligon Brian | President/CEO | Mar 23, 2023 | Option Exercise | $7.69 | 7,437 | 57,191 | 152,563 | Mar 27, 2023, 08:05 PM |
| McKelligon Brian | President/CEO | Mar 14, 2023 | Option Exercise | $0.30 | 5,000 | 1,515 | 165,000 | Mar 16, 2023, 04:20 PM |
| McKelligon Brian | President/CEO | Mar 14, 2023 | Sale | $9.17 | 5,000 | 45,852 | 160,226 | Mar 16, 2023, 04:20 PM |
| Ramachandran Niro Ph.D | Chief Business Officer | Feb 15, 2023 | Option Exercise | $0.91 | 34,000 | 30,940 | 156,680 | Feb 17, 2023, 05:10 PM |
| DRISCOLL JOSEPH | Chief Financial Officer | Dec 22, 2022 | Option Exercise | $0.44 | 250,000 | 110,000 | 262,500 | Dec 27, 2022, 04:05 PM |
| SCHNETTLER THOMAS P | Director | Dec 13, 2022 | Sale | $13.03 | 71,050 | 925,781 | 2,742,721 | Dec 20, 2022, 04:02 PM |
| DRISCOLL JOSEPH | Chief Financial Officer | Dec 14, 2022 | Option Exercise | $0.44 | 24,613 | 10,830 | 27,074 | Dec 16, 2022, 05:59 PM |
| DRISCOLL JOSEPH | Chief Financial Officer | Dec 14, 2022 | Sale | $12.54 | 24,613 | 308,706 | 12,500 | Dec 16, 2022, 05:59 PM |
| Nolan Garry Ph.D. | Director | Dec 13, 2021 | Sale | $13.25 | 100 | 1,325 | 555,084 | Dec 15, 2022, 07:07 PM |
| McKelligon Brian | President/CEO | Dec 06, 2022 | Option Exercise | $0.30 | 5,000 | 1,515 | 85,000 | Dec 08, 2022, 04:01 PM |
| McKelligon Brian | President/CEO | Dec 06, 2022 | Sale | $12.08 | 5,000 | 60,415 | 80,000 | Dec 08, 2022, 04:01 PM |
| Nolan Garry Ph.D. | Director | Dec 02, 2022 | Sale | $13.25 | 1,100 | 14,575 | 591,978 | Dec 06, 2022, 06:29 PM |
| Nolan Garry Ph.D. | Director | Dec 01, 2022 | Sale | $13.36 | 5,000 | 66,788 | 593,078 | Dec 02, 2022, 04:00 PM |
| Nolan Garry Ph.D. | Director | Nov 16, 2022 | Sale | $13.25 | 300 | 3,976 | 598,078 | Nov 17, 2022, 06:21 PM |
| Nolan Garry Ph.D. | Director | Nov 11, 2022 | Sale | $13.29 | 20,000 | 265,858 | 598,978 | Nov 14, 2022, 06:43 PM |
| Nolan Garry Ph.D. | Director | Nov 10, 2022 | Sale | $13.31 | 3,810 | 50,705 | 618,978 | Nov 14, 2022, 06:43 PM |
| Nolan Garry Ph.D. | Director | Nov 14, 2022 | Sale | $13.28 | 600 | 7,966 | 598,378 | Nov 14, 2022, 06:43 PM |
| Nolan Garry Ph.D. | Director | Sep 14, 2022 | Sale | $13.26 | 8,305 | 110,084 | 622,788 | Sep 16, 2022, 07:07 PM |
| Nolan Garry Ph.D. | Director | Sep 12, 2022 | Sale | $13.30 | 1,800 | 23,944 | 631,093 | Sep 13, 2022, 04:07 PM |
| Nolan Garry Ph.D. | Director | Sep 09, 2022 | Sale | $13.31 | 22,191 | 295,338 | 632,893 | Sep 13, 2022, 04:07 PM |
| McKelligon Brian | President/CEO | Sep 07, 2022 | Option Exercise | $0.30 | 5,000 | 1,515 | 85,000 | Sep 09, 2022, 04:00 PM |
| McKelligon Brian | President/CEO | Sep 07, 2022 | Sale | $12.83 | 5,000 | 64,170 | 80,000 | Sep 09, 2022, 04:00 PM |
| Ramachandran Niro Ph.D | Chief Business Officer | Apr 13, 2022 | Option Exercise | $0.91 | 75,107 | 68,347 | 122,680 | Apr 14, 2022, 03:23 PM |
| Nolan Garry Ph.D. | Director | Dec 09, 2021 | Sale | $12.67 | 25,000 | 316,762 | 655,084 | Dec 13, 2021, 06:06 PM |
| Ramachandran Niro Ph.D | Chief Business Officer | Nov 22, 2021 | Buy | $13.13 | 25,000 | 328,292 | 25,073 | Nov 22, 2021, 08:27 PM |
| Ramachandran Niro Ph.D | Chief Business Officer | Nov 19, 2021 | Buy | $12.85 | 73 | 938 | 73 | Nov 22, 2021, 08:27 PM |
| Mendel Scott | Director | Nov 19, 2021 | Buy | $13.16 | 8,500 | 111,860 | 8,500 | Nov 19, 2021, 12:55 PM |
| SHEPLER ROBERT G | Director | Nov 18, 2021 | Buy | $12.60 | 35,000 | 441,005 | 35,000 | Nov 18, 2021, 09:08 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Ek John Frederick | CFO | 04/01/2024 | 65,080 |
| Pla Frederic | Chief Operating Officer | 03/23/2024 | 9,609 |
| Ramachandran Niro Ph.D | Chief Business Officer | 03/23/2024 | 9,609 |
| McKelligon Brian | President and CEO | 03/23/2024 | 34,177 |
| McKelligon Brian | President and CEO | 03/20/2024 | 2,273 |
| McKelligon Brian | President and CEO | 03/20/2024 | 37,243 |
| McKelligon Brian | President and CEO | 03/13/2024 | 2,273 |
| McKelligon Brian | President and CEO | 03/13/2024 | 37,043 |
| McKelligon Brian | President and CEO | 03/13/2024 | 37,035 |
| McKelligon Brian | President and CEO | 03/01/2024 | 49,416 |
| Kamocsay Jennifer | General Counsel | 03/01/2024 | 19,796 |
| Pla Frederic | Chief Operating Officer | 03/01/2024 | 12,355 |
| Ramachandran Niro Ph.D | Chief Business Officer | 03/01/2024 | 13,899 |
| McKelligon Brian | President and CEO | 03/01/2024 | 61,771 |
| McKelligon Brian | President and CEO | 12/19/2023 | 2,273 |
| McKelligon Brian | President and CEO | 12/19/2023 | 33,565 |
| McKelligon Brian | President and CEO | 12/12/2023 | 2,273 |
| McKelligon Brian | President and CEO | 12/12/2023 | 31,871 |
| Pla Frederic | Chief Operating Officer | 09/07/2023 | 92,014 |
| Ek John Frederick | CFO | 06/12/2023 | 100,000 |
| LAI GOLDMAN MYLA | Director | 06/12/2023 | 100,000 |
| Mendel Scott | Director | 06/12/2023 | 100,000 |
| Winkler Matthew | Director | 06/12/2023 | 1,016,940 |
| SHEPLER ROBERT G | Director | 06/12/2023 | 600,000 |
| Raffin Thomas A. | Director | 06/12/2023 | 10,000,000 |
| Raffin Thomas A. | Director | 06/12/2023 | 100,000 |
| McKelligon Brian | President/CEO | 06/06/2023 | 1,515 |
| McKelligon Brian | President/CEO | 06/06/2023 | 28,537 |
| Nolan Garry Ph.D. | Director | 12/13/2022 | 1,325 |
| Ramachandran Niro Ph.D | Chief Business Officer | 03/23/2023 | 14,957 |
| Pla Frederic | Chief Operating Officer | 03/23/2023 | 14,957 |
| McKelligon Brian | President/CEO | 03/23/2023 | 57,191 |
| McKelligon Brian | President/CEO | 03/14/2023 | 1,515 |
| McKelligon Brian | President/CEO | 03/14/2023 | 45,852 |
| Ramachandran Niro Ph.D | Chief Business Officer | 02/15/2023 | 30,940 |
| DRISCOLL JOSEPH | Chief Financial Officer | 12/22/2022 | 110,000 |
| SCHNETTLER THOMAS P | Director | 12/13/2022 | 925,781 |
| DRISCOLL JOSEPH | Chief Financial Officer | 12/14/2022 | 10,830 |
| DRISCOLL JOSEPH | Chief Financial Officer | 12/14/2022 | 308,706 |
| Nolan Garry Ph.D. | Director | 12/13/2021 | 1,325 |
| McKelligon Brian | President/CEO | 12/06/2022 | 1,515 |
| McKelligon Brian | President/CEO | 12/06/2022 | 60,415 |
| Nolan Garry Ph.D. | Director | 12/02/2022 | 14,575 |
| Nolan Garry Ph.D. | Director | 12/01/2022 | 66,788 |
| Nolan Garry Ph.D. | Director | 11/16/2022 | 3,976 |
| Nolan Garry Ph.D. | Director | 11/11/2022 | 265,858 |
| Nolan Garry Ph.D. | Director | 11/10/2022 | 50,705 |
| Nolan Garry Ph.D. | Director | 11/14/2022 | 7,966 |
| Nolan Garry Ph.D. | Director | 09/14/2022 | 110,084 |
| Nolan Garry Ph.D. | Director | 09/12/2022 | 23,944 |
| Nolan Garry Ph.D. | Director | 09/09/2022 | 295,338 |
| McKelligon Brian | President/CEO | 09/07/2022 | 1,515 |
| McKelligon Brian | President/CEO | 09/07/2022 | 64,170 |
| Ramachandran Niro Ph.D | Chief Business Officer | 04/13/2022 | 68,347 |
| Nolan Garry Ph.D. | Director | 12/09/2021 | 316,762 |
| Ramachandran Niro Ph.D | Chief Business Officer | 11/22/2021 | 328,292 |
| Ramachandran Niro Ph.D | Chief Business Officer | 11/19/2021 | 938 |
| Mendel Scott | Director | 11/19/2021 | 111,860 |
| SHEPLER ROBERT G | Director | 11/18/2021 | 441,005 |
Load More Insider Transactions
FUNDS WITH A POSITION IN AKOYA BIOSCIENCES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 1,372,232 | 0.00017% | -5.04% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 498,175 | 0.00025% | 6.89% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 47,400 | 0.00036% | -77.7% | Other |
CHANGE IN SHARES OUTSTANDING FOR AKOYA BIOSCIENCES INC
STOCK BUYBACKS FOR AKOYA BIOSCIENCES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
1.44%
1Q
06/30/2023
22.25%
2Q
03/31/2023
29.62%
3Q
12/31/2022
30.72%
4Q
09/30/2022
31.08%
5Q
06/30/2022
32.08%
6Q
03/31/2022
32.61%
7Q
12/31/2021
84.71%
8Q
09/30/2021
33.68%
9Q
06/30/2021
65.74%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AKOYA BIOSCIENCES INC
LOADING...